Literature DB >> 18823491

The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women.

K Zetterström1, S N Lindeberg, B Haglund, U Hanson.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether there is a difference, by gender, in perinatal mortality in chronically hypertensive women compared with normotensive women.
DESIGN: Population-based prospective cohort study.
SETTING: Sweden. POPULATION: A total of 866,188 women with singleton pregnancies registered in the Swedish Medical Birth Registry 1992-2004, of which 4749 were diagnosed with chronic hypertension.
METHODS: Multivariate logistic regression analysis was performed. In a first step, we adjusted for maternal characteristics and in a second step for mild and severe pre-eclampsia, gestational diabetes, placental abruption and small for gestational age. An effect modification by gender was included in the model. MAIN OUTCOME MEASURES: Odds ratios (OR) for intrauterine death, neonatal death and post-neonatal death with respect to gender of offspring.
RESULTS: The unadjusted OR of intrauterine death was 4.12 (95% CI: 2.84-5.96) and 1.29 (95% CI: 0.67-2.48) for male and female offspring, respectively, and of neonatal death, it was 3.45 (95% CI: 2.13-5.59) and 2.17 (95% CI: 1.08-4.35) for male and female offspring, respectively. After multivariate analysis, the OR of intrauterine death was 3.07 (95% CI: 2.12-4.46) and neonatal death was 2.99 (95% CI: 1.84-4.85) for male offspring. For female offspring, the OR of intrauterine death was 0.98 (95% CI: 0.51-1.89) and neonatal death was 1.88 (95% CI: 0.93-3.79).
CONCLUSION: Mothers with chronic hypertension have an increased risk of perinatal mortality of their male offspring.

Entities:  

Mesh:

Year:  2008        PMID: 18823491     DOI: 10.1111/j.1471-0528.2008.01844.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  8 in total

1.  Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions.

Authors:  Brian T Bateman; Pooja Bansil; Sonia Hernandez-Diaz; Jill M Mhyre; William M Callaghan; Elena V Kuklina
Journal:  Am J Obstet Gynecol       Date:  2011-11-07       Impact factor: 8.661

2.  Chronic hypertension, perinatal mortality and the impact of preterm delivery: a population-based study.

Authors:  S Grover; J S Brandt; U M Reddy; C V Ananth
Journal:  BJOG       Date:  2021-10-06       Impact factor: 7.331

Review 3.  Maternal preeclampsia and risk for cardiovascular disease in offspring.

Authors:  Guadalupe Herrera-Garcia; Stephen Contag
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 4.  Stress and Androgen Activity During Fetal Development.

Authors:  Emily S Barrett; Shanna H Swan
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

5.  Foetal aortic flow velocity waveforms in healthy and hypertensive pregnant women.

Authors:  Luís Guedes-Martins; Ana Cunha; Joaquim Saraiva; Ana Rita-Gaio; Ana S Cerdeira; Filipe Macedo; Henrique Almeida
Journal:  Cardiovasc Ultrasound       Date:  2014-01-27       Impact factor: 2.062

6.  Risk factors for perinatal death in two different levels of care: a case-control study.

Authors:  Paula Maria Silveira Soares Moura; Izildinha Maestá; Lígia Maria Souza Suppo Rugolo; Luís Felipe Ramos Berbel Angulski; Antônio Prates Caldeira; José Carlos Peraçoli; Marilza Vieira Cunha Rudge
Journal:  Reprod Health       Date:  2014-01-30       Impact factor: 3.223

7.  Congenital cerebral palsy, child sex and parent cardiovascular risk.

Authors:  Elani Streja; Chunsen Wu; Peter Uldall; Jakob Grove; Onyebuchi Arah; Jørn Olsen
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

Review 8.  Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis.

Authors:  Kate Bramham; Bethany Parnell; Catherine Nelson-Piercy; Paul T Seed; Lucilla Poston; Lucy C Chappell
Journal:  BMJ       Date:  2014-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.